NO970785D0 - Fremgangsmåte for benheling og fraktur-reparasjon - Google Patents

Fremgangsmåte for benheling og fraktur-reparasjon

Info

Publication number
NO970785D0
NO970785D0 NO970785A NO970785A NO970785D0 NO 970785 D0 NO970785 D0 NO 970785D0 NO 970785 A NO970785 A NO 970785A NO 970785 A NO970785 A NO 970785A NO 970785 D0 NO970785 D0 NO 970785D0
Authority
NO
Norway
Prior art keywords
bone healing
fracture repair
procedures
image
hexamethyleneamino
Prior art date
Application number
NO970785A
Other languages
English (en)
Other versions
NO970785L (no
Inventor
George Joseph Cullinan
Masahiko Sato
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO970785D0 publication Critical patent/NO970785D0/no
Publication of NO970785L publication Critical patent/NO970785L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO970785A 1994-08-22 1997-02-20 Fremgangsmåte for benheling og fraktur-reparasjon NO970785L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/294,130 US5502074A (en) 1994-08-22 1994-08-22 Benzothiophenes for bone healing and fracture repair
PCT/US1995/010618 WO1996005825A1 (en) 1994-08-22 1995-08-21 Methods for bone healing and fracture repair

Publications (2)

Publication Number Publication Date
NO970785D0 true NO970785D0 (no) 1997-02-20
NO970785L NO970785L (no) 1997-02-20

Family

ID=23132010

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970785A NO970785L (no) 1994-08-22 1997-02-20 Fremgangsmåte for benheling og fraktur-reparasjon

Country Status (20)

Country Link
US (1) US5502074A (no)
EP (1) EP0769945B1 (no)
JP (1) JPH10504578A (no)
KR (1) KR970705385A (no)
AT (1) ATE240101T1 (no)
AU (1) AU701946B2 (no)
CA (1) CA2198012A1 (no)
CZ (1) CZ51997A3 (no)
DE (1) DE69530771T2 (no)
DK (1) DK0769945T3 (no)
ES (1) ES2197207T3 (no)
FI (1) FI970715A (no)
HU (1) HUT76855A (no)
IL (1) IL115016A (no)
MX (1) MX9701332A (no)
NO (1) NO970785L (no)
PH (1) PH31620A (no)
PT (1) PT769945E (no)
WO (1) WO1996005825A1 (no)
ZA (1) ZA956989B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856340A (en) 1995-02-28 1999-01-05 Eli Lilly And Company Method of treating estrogen dependent cancers
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
AU5862199A (en) * 1998-09-11 2000-04-03 Michael Raschke Biologically active implants
DK1175433T3 (da) 1999-05-04 2005-09-19 Strakan Int Ltd Androgenglycosider og androgen aktivitet deraf

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
DE4122484A1 (de) * 1991-07-06 1993-01-07 Teves Gmbh Alfred Schaltungsanordnung zur erkennung von radsensordefekten
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
TW303299B (no) * 1993-07-22 1997-04-21 Lilly Co Eli

Also Published As

Publication number Publication date
IL115016A (en) 1999-09-22
WO1996005825A1 (en) 1996-02-29
PT769945E (pt) 2003-09-30
FI970715A0 (fi) 1997-02-20
FI970715A (fi) 1997-02-20
CZ51997A3 (en) 1997-08-13
CA2198012A1 (en) 1996-02-29
MX9701332A (es) 1997-05-31
HUT76855A (en) 1997-12-29
ES2197207T3 (es) 2004-01-01
DE69530771T2 (de) 2004-03-11
JPH10504578A (ja) 1998-05-06
DK0769945T3 (da) 2003-06-10
AU3409795A (en) 1996-03-14
PH31620A (en) 1999-01-12
ZA956989B (en) 1997-02-21
EP0769945A1 (en) 1997-05-02
EP0769945A4 (en) 1997-09-03
AU701946B2 (en) 1999-02-11
ATE240101T1 (de) 2003-05-15
EP0769945B1 (en) 2003-05-14
US5502074A (en) 1996-03-26
DE69530771D1 (de) 2003-06-18
IL115016A0 (en) 1995-12-08
NO970785L (no) 1997-02-20
KR970705385A (ko) 1997-10-09

Similar Documents

Publication Publication Date Title
GR3033269T3 (en) Methods of inhibiting viral replication
NO970786L (no) Fremgangsmåte for hemming av benprotesedegradering
EA199700136A1 (ru) Способы ингибирования экзогенных эстрогенов
NO970785L (no) Fremgangsmåte for benheling og fraktur-reparasjon
NO971794L (no) Fremgangsmåte for hemming av tilstander forbundet med bradykinin
MX9702148A (es) Metodos para inhibir la mitosis endometrial.
MX9701327A (es) Metodos para inhibir el cancer endometrial.
MX9701331A (es) Metodos para mantener los dientes y los huesos bucales.
DK0771201T3 (da) Anvendelse af 2-phenyl-3-aroylbenzothiophener til fremstilling af et medikament til inhibering af primær endometrisk hyperplasi
DK0772438T3 (da) Anvendelse af benzothiophener til fremstilling af et medikament til reduktion af ardannelse under sårheling
MX9709536A (es) Metodo para reducir el factor de transcripcion bef-1.